<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12951-021-00903-7</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">12951</journal-id><journal-title-group><journal-title>Journal of Nanobiotechnology</journal-title><abbrev-journal-title abbrev-type="publisher">J Nanobiotechnol</abbrev-journal-title></journal-title-group><issn pub-type="epub">1477-3155</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12951-021-00903-7</article-id><article-id pub-id-type="manuscript">903</article-id><article-id pub-id-type="doi">10.1186/s12951-021-00903-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Liu</surname><given-names>Zhaoyuan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Xie</surname><given-names>Zhongjian</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Li</surname><given-names>Wenting</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Wu</surname><given-names>Xinqiang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Jiang</surname><given-names>Xiaofeng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Li</surname><given-names>Guanhua</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Cao</surname><given-names>Liangqi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Zhang</surname><given-names>Dawei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Wang</surname><given-names>Qiwen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au10"><name><surname>Xue</surname><given-names>Ping</given-names></name><address><email>gyeyxueping@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs12951021009037_cor10">k</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au11"><name><surname>Zhang</surname><given-names>Han</given-names></name><address><email>hzhang@szu.edu.cn</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="corresp" rid="IDs12951021009037_cor11">m</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412534.5</institution-id><institution content-type="org-division">Department of Hepatobiliary Surgery</institution><institution content-type="org-name">The Second Affiliated Hospital of Guangzhou Medical University</institution></institution-wrap><addr-line content-type="postcode">510260</addr-line><addr-line content-type="city">Guangzhou</addr-line><country country="CN">China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412534.5</institution-id><institution content-type="org-division">Department of Traditional Chinese Medicine</institution><institution content-type="org-name">The Second Affiliated Hospital of Guangzhou Medical University</institution></institution-wrap><addr-line content-type="postcode">510260</addr-line><addr-line content-type="city">Guangzhou</addr-line><country country="CN">China</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.263488.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0472 9649</institution-id><institution content-type="org-division">Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Collaborative Innovation Centre for Optoelectronic Science &amp; Technology, Institute of Microscale Optoelectronics</institution><institution content-type="org-name">Shenzhen University</institution></institution-wrap><addr-line content-type="postcode">518060</addr-line><addr-line content-type="city">Shenzhen</addr-line><country country="CN">China</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.263488.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0472 9649</institution-id><institution content-type="org-division">College of Physics and Optoelectronic Engineering</institution><institution content-type="org-name">Shenzhen University</institution></institution-wrap><addr-line content-type="postcode">518060</addr-line><addr-line content-type="city">Shenzhen</addr-line><country country="CN">China</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.263488.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0472 9649</institution-id><institution content-type="org-division">Shenzhen Key Laboratory of Micro-Nano Photonic Information Technology, Guangdong Laboratory of Artificial Intelligence and Digital Economy (SZ)</institution><institution content-type="org-name">Shenzhen University</institution></institution-wrap><addr-line content-type="postcode">518060</addr-line><addr-line content-type="city">Shenzhen</addr-line><country country="CN">China</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution content-type="org-division">Department of Cardiovascular Surgery, Sun Yat-Sen Memorial Hospital</institution><institution content-type="org-name">Sun Yat-Sen University</institution></institution-wrap><addr-line content-type="postcode">510120</addr-line><addr-line content-type="city">Guangzhou</addr-line><addr-line content-type="state">Guangdong</addr-line><country country="CN">China</country></aff></contrib-group><author-notes><fn fn-type="con"><p>Zhaoyuan Liu, Zhongjian Xie and Wenting Li are joint first authors</p></fn><corresp id="IDs12951021009037_cor10"><label>k</label><email>gyeyxueping@163.com</email></corresp><corresp id="IDs12951021009037_cor11"><label>m</label><email>hzhang@szu.edu.cn</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>5</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2021</year></pub-date><volume>19</volume><issue seq="160">1</issue><elocation-id>160</elocation-id><history><date date-type="registration"><day>20</day><month>5</month><year>2021</year></date><date date-type="received"><day>3</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2021</year></date><date date-type="online"><day>29</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement content-type="compact">Â© The Author(s) 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="uri">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><p id="Par1">Photodynamic therapy (PDT) is a non-invasive or minimally-invasive treatment which applies photosensitizers (PSs) to create reactive oxygen species (ROS) exposed to light trigger to destroy cancer cells. PDT can activate host anti-tumor immune responses but not powerful enough to kill metastatic tumors. Because of its carrier advantage, imaging, and therapeutic function together with enhanced permeability and retention (EPR) effect, nano-materials have already been used in photo-immunotherapy. Herein, photodynamic immunotherapy (PDIT) based on nanotechnology seems to be a hopeful new form of cancer therapy. In this article, we firstly summarize the recent development in photodynamic immunotherapy based on nanotechnology.</p><p><fig id="Figa" position="anchor"><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Figa_HTML.png" position="anchor" id="MO100"/></fig></p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Photodynamic therapy</kwd><kwd>Nanotechnology</kwd><kwd>Immunotherapy</kwd><kwd>Cancer treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>160</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2021</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2021</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2021</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>20</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12951_2021_Article_903.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Chemistry</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Molecular Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Chemistry and Materials Science</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par2">Cancer still accounts for a primary cause of death across the world. Cancer is characteristic of poor prognosis and high mortality despite systemic therapy such as chemotherapy and radiation. Metastasis and recurrence are two thorny issues in treating cancer. Primary tumors can be treated with surgery, chemotherapy, radiotherapy, and so forth. Unfortunately, metastasis and recurrence will eventually lead to the death of cancer patients [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par3">Photodynamic therapy (PDT) uses photosensitizers (PSs), oxygen, and light to destroy tumors through direct cell kill, microvascular disruption, and inflammation [<xref ref-type="bibr" rid="CR2">2</xref>]. PDT has lower side effects and systemic toxicity than chemotherapy and radiation therapy. PDT has been sanctioned by the Food and Drug Administration of America for clinical use in treating a variety of solid tumors [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par4">PDT uses reactive oxygen species (ROS) created by PS under the light trigger to kill tumors. ROS has a very short life span and narrow radius, especially for singlet oxygen [<xref ref-type="bibr" rid="CR4">4</xref>]. Precise targeting of PDT is critical for delivering photosensitizers to wanted areas to produce ROS. PDT is a very effective treatment for skin lesions and esophageal cancer but can not destroy deep tumors due to the shallow light penetration through tissues [<xref ref-type="bibr" rid="CR5">5</xref>]. Most photosensitizers for PDT are hydrophobic and suboptimally selective in vivo [<xref ref-type="bibr" rid="CR6">6</xref>]. To solve these problems, nanomaterials that are hydrophilic and can be used as drug delivery have been conjugated with conventional photosensitizers. Nanomaterials can passively accumulate in tumors via enhanced permeability and retention (EPR) effect [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR10">10</xref>], which is crucial for an effective PDT that minimizes collateral damage to surrounding healthy tissues. Therefore, a large amount of nano-delivery systems have been designed to meet this requirement.</p><p id="Par5">PDT has shown the ability to induce anti-tumor immunity. However, the anti-tumor immune response caused by PDT is usually mild. Tumor hypoxia can inhibit T cells from entering tumor areas to cause immune suppression [<xref ref-type="bibr" rid="CR11">11</xref>]. PDT has been shown to induce immunogenic cell death (ICD) and release tumor-associated antigens during the destruction of cancer cells, leading to activation and proliferation of CD8<sup>+</sup> T lymphocytes [<xref ref-type="bibr" rid="CR12">12</xref>]. However, the therapeutic effect of PDT on metastasis and recurrence is still weak.</p><p id="Par6">Nanomaterials are defined as particles between 1 and 100Â nm in size. Traditional organic PSs are hydrophobic, unstable, and unspecific in vivo when applied in PDT. So, nanomaterials with excellent physical and chemical properties have been constructed to solve these problems [<xref ref-type="bibr" rid="CR13">13</xref>]. Nanomaterials are general terms of 0D, 1D, 2D, and 3D materials with small size effects, which are composed of ultrafine particles with sizes less than 100Â nm (0.1â100Â nm). According to the geometric structure, nanomaterials include 0D materials (quantum dots), 1D nanomaterials (nanotubes or nanowires), 2D nanomaterials (thin films), and three-dimensional (3D) nanomaterials. The extraordinary interaction of light and matter gives low-dimensional materials the potential for photodynamic therapy. 0D materials are promising nanocarriers for their high emission quantum yield, tunable emission, and facile surface modification. The versatile surface modification of 1D nanomaterials can make them excellent PDT agents. 2D nanomaterials have gained extensive attention for their unprecedented technological advances [<xref ref-type="bibr" rid="CR14">14</xref>â<xref ref-type="bibr" rid="CR17">17</xref>]. Many 2D nanomaterials have been constructed and applied in photo-detection [<xref ref-type="bibr" rid="CR18">18</xref>â<xref ref-type="bibr" rid="CR20">20</xref>], optical application [<xref ref-type="bibr" rid="CR21">21</xref>â<xref ref-type="bibr" rid="CR25">25</xref>], fiber laser [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], environmental science [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] and energy [<xref ref-type="bibr" rid="CR30">30</xref>]. 2D materials have low toxicity, high stability, good biocompatibility, tunable composition, facile surface modifications, and strong interaction with light. These features are ideal for a variety of PDT applications. 2D black phosphorus has been used in photodynamic therapy and drug delivery [<xref ref-type="bibr" rid="CR31">31</xref>]. 3D nanomaterials are hydrophobic and exhibit intrinsic toxicity, many modifications need to make to overcome these issues (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR32">32</xref>â<xref ref-type="bibr" rid="CR45">45</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Nanomaterials applying in PDT</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Nanomaterials</p></th><th align="left"><p>Promising properties</p></th><th align="left"><p>Improvements</p></th><th align="left"><p>Toxicity</p></th></tr></thead><tbody><tr><td align="left" colspan="4"><p>0D</p></td></tr><tr><td align="left"><p>Â Quantum dots(QDs) [<xref ref-type="bibr" rid="CR32">32</xref>â<xref ref-type="bibr" rid="CR35">35</xref>]</p></td><td align="left"><p>High emission quantum yield, tunable emission, promising carrier, good biocompatibility, deep PDT</p></td><td align="left"><p>Release of heavy metals from the QD cores</p></td><td align="left"><p>Potential toxic effects</p></td></tr><tr><td align="left" colspan="4"><p>1D</p></td></tr><tr><td align="left"><p>Â Carbon nanotubes [<xref ref-type="bibr" rid="CR36">36</xref>]</p></td><td align="left"><p>Versatile surface modifications, drug delivery</p></td><td align="left"><p>Lack of standardized synthetic protocols</p></td><td align="left"><p>Low toxicity</p></td></tr><tr><td align="left"><p>2D</p></td><td align="left"/><td align="left"><p>Get appropriate lateral size with large-scale production, tumor-targeting efficiency, biocompatibility</p></td><td align="left"><p>Low toxicity</p></td></tr><tr><td align="left"><p>Â Manganese dioxide (MnO<sub>2</sub>) nanosheets [<xref ref-type="bibr" rid="CR37">37</xref>â<xref ref-type="bibr" rid="CR39">39</xref>]</p></td><td align="left"><p>Regenerate oxygen, carrier, good biocompatibility</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>Â 2D transition metal dichalcogenide (TMD) nanosheets [<xref ref-type="bibr" rid="CR40">40</xref>]</p></td><td align="left"><p>High specific surface area, good biocompatibility, facile modification, and ultrahigh light and heat conversion efficiencies</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>Â Graphitic-phase carbon nitride (g-C<sub>3</sub>N<sub>4</sub>) nanosheets [<xref ref-type="bibr" rid="CR41">41</xref>]</p></td><td align="left"><p>High stability, good biocompatibility, and high photoluminescence quantum yields</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>Â Black phosphorus (BP) [<xref ref-type="bibr" rid="CR42">42</xref>â<xref ref-type="bibr" rid="CR44">44</xref>]</p></td><td align="left"><p>Exceptional structural, optical and chemical properties, impressive carrier mobility, good biocompatibility and biodegradability inside the human body</p></td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="4"><p>3D</p></td></tr><tr><td align="left"><p>Â Fullerenes [<xref ref-type="bibr" rid="CR45">45</xref>]</p></td><td align="left"><p>Drug delivery</p></td><td align="left"><p>Poorly soluble in water</p></td><td align="left"><p>Intrinsic toxicity</p></td></tr></tbody></table></table-wrap></p><p id="Par7">In recent years, cancer immunotherapy has become an effective method to treat various malignant and metastatic tumors. Cancer immunotherapy has shown the ability to destroy residual tumors but often fails to kill primary tumors [<xref ref-type="bibr" rid="CR46">46</xref>]. Cancer immunotherapy remains restricted to patient benefits and circumscribed anti-tumor efficacy despite significant advances [<xref ref-type="bibr" rid="CR47">47</xref>]. Nanomaterials can carry immune adjuvants or immunosuppressants to specific sites in the tumor. Therefore, the combination of PDT and immunotherapy based on nanotechnology might be the solution.</p></sec><sec id="Sec2"><title>Nano-targeted photodynamic immunotherapy</title><p id="Par8">Nano-targeted Photodynamic immunotherapy is a combination of PDT and molecular-targeted therapy based on nanotechnology. Nano-targeted Photodynamic immunotherapy exhibit better tumor targeting and killing but less toxicity as compared to conventional PDT.</p><sec id="Sec3"><title>Tumor-targeted nano-photodynamic immunotherapy</title><p id="Par9">Hepatocellular carcinoma (HCC) is one of the most deadly diseases in the world, but only a little part of patients with HCC are eligible for curative surgery. Therefore, new types of therapy are imperative for the treatment of HCC. The biomarkers of HCC cell surface such as epithelial cell adhesion molecule (EpCAM) [<xref ref-type="bibr" rid="CR48">48</xref>] and Glypican-3 (GPC3) [<xref ref-type="bibr" rid="CR49">49</xref>] are amenable for the development of photodynamic immunotherapy based on antibody-photosensitizer conjugate (APC) strategy.</p><p id="Par10">Hanaoka et al. reported that in vitro animal experiments have shown that antibody-targeted photodynamic immune nanomaterials rapidly aggregate in tumor sites. Within 60Â min after the injection in animals treated with photodynamic immunotherapy (PIT), the tumor became visible and the target background ratio (TBR) was greater. This showed that IR700-YP7 PIT could significantly increase the accumulation of nano-drugs to the tumor area, thus improving drug efficacy (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>a) [<xref ref-type="bibr" rid="CR49">49</xref>]. As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>b [<xref ref-type="bibr" rid="CR48">48</xref>], Significant green luminescence was observed in both groups. Besides, anti-EpCAM-UPG micelle treated mice expressed stronger signals, showing excellent in vivo activity targeting ability. Compared with untargeted micelles that showed passive tumor targeting capability only, anti-EpCAM-conjugated micelles had active and passive targeting capabilities, resulting in a higher tumor aggregation rate of micelles in tumors even after 48Â h. Compared with the non-targeted group, the mean fluorescence intensity of the targeted group at 8Â h, 24Â h, and 48Â h showed a significant difference. By EPR effect, the fluorescence signal gradually decreased 24Â h after injection.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p><bold>a</bold> Dynamic images and continuous TBR of IR800-nab-paclitaxel over time for A431/G1 tumors only after IR700-YP7-mediated nuclear or near-infrared irradiation. IR800-nab-paclitaxel had rapid, high accumulations, and high TBR in acute PIT treated tumors compared with untreated tumors [<xref ref-type="bibr" rid="CR49">49</xref>] Copyright Â©2015 Future Science Group. <bold>b</bold> Comparison of mean fluorescence intensity between the anti-EPCam-UPG (targeted) and the UPG micellar (nontargeted) at different time points before and after injection of targeted and nontargeted groups in tumor-bearing mice [<xref ref-type="bibr" rid="CR48">48</xref>] </p><p>(Copyright Â©2018 Royal Society of Chemistry)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig1_HTML.png" id="MO1"/></fig></p><p id="Par11">Yu et al. reported that PDT-stimulated anti-tumor immunity is related to the damage of tumor cells. Necrotic tumor cells caused by tumor integrin Î±vÎ²6-targeting PDT activated dendritic cells to increase CD8<sup>+</sup>T cell infiltration in the tumor [<xref ref-type="bibr" rid="CR50">50</xref>]. There were more lung metastases in the control group (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>a). By comparison, lung metastatic growth was significantly lower in the inoculation group than in the control group (Pâ&lt;â0.001). The tumor microenvironment (TME) could be a new target for enhanced photoimmunotherapy against cancer. Fibroblast-activation protein (FAP) is expressed on carcinoma-associated fibroblast (CAF), which is an important part of tumor extracellular matrix (ECM). Zhen et al. reported that FAP-targeted PDT led to ECM deposition and enhanced T cell infiltration significantly, and then effectively suppress tumor [<xref ref-type="bibr" rid="CR51">51</xref>]. IF microscopy showed a significant increase in the number of CD8<sup>+</sup>T cells in tumors after one or two doses of PIT (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>b). Positive staining in tumors was increased by 6.13 times in the 1 dose PIT group and 19.0 times in the 2 dose PIT group compared with the control group (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>c). At the same time, increased neutrophil infiltration was observed on the H&amp;E staining too (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>d). In the control group, a lot of cellular islets separated by a thick layer of collagen were observed on tumor slices. After PIT, significant ECM destruction and fewer cell colonies were observed (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>e).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p><bold>a</bold> Quantitative analysis of lung metastases and H&amp;E staining of lung tissue. intrapulmonary metastasis showed by arrows[<xref ref-type="bibr" rid="CR50">50</xref>] Copyright Â© 2017 American Chemical Society. <bold>b</bold> Anti-CD8a dyeing. "C" &amp; "P" represent central and peripheral areas of the tumor, respectively. <bold>c</bold> Fluorescence intensity-based tumor CD8+ T cell frequency **, Pâ&lt;â0.01. <bold>d</bold> H&amp;E staining of tumor tissue. Yellow arrows, neutrophils. <bold>e</bold> Trichrome staining results. black/blue, nuclei; red, muscle fibers; Blue, collagen [<xref ref-type="bibr" rid="CR51">51</xref>] </p><p>(Copyright Â© 2016 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig2_HTML.png" id="MO2"/></fig></p><p id="Par12">For large solid tumors such as HCC, tumor-targeted PDT can indeed enhance efficacy, but it is less likely that it will also be effective in the center of the tumor due to the interstitial obstruction of the tumor. Tumor stromal targeted PDT seems to solve this problem.</p></sec><sec id="Sec4"><title>Vascular-targeted nano-photodynamic immunotherapy</title><p id="Par13">Oxygen is sufficient in blood vessels, making it a perfect target for PDT by producing ROS, which also destroys vascular endothelial cells causing vessel disruption. Guan et al. reported that tumor vascular destruction PDT promoted dendritic cells (DCs) to mature, and then secreted interleukin-12 (IL-12) and tumor necrosis factor-Î± (TNF-Î±), which activate T lymphocytes by upregulating the differentiated clusters of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes. Besides, the down-regulation of matrix metalloprotein 2 (MMP2) and MMP9 also reduced the rate of tumor metastasis [<xref ref-type="bibr" rid="CR52">52</xref>]. First, the nano-gadofullerene (Gd@C82-Ala, abbreviated Gd-Ala) was injected and simultaneously exposed to light. Activated Gd-Ala can utilize the oxygen of blood vessels to create ROS, to block blood vessels via effectively destroying endothelial cells. Then, the activated GD-Ala promoted endothelial cells to maturation, which secreted TNF-Î± and IL-12, thereby activating T lymphocytes by upregulating CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes differentiation clusters. Besides, down-regulation of MMP2 and MMP9 reduced tumor metastasis too. Photo-triggered Gd-Ala can destroy tumor blood vessels and inhibit metastatic tumors (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>a). To understand real-time changes of vessels in the GD-Ala-based V-PDT process, a model of 4T1-Luc tumor cells implanted in the dorsal skinfold chamber (DSFC) was built. The large-scale skin of the mouse is used for angiography, which has high optical clarity. The changes of blood vessels are shown in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>b.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p><bold>a</bold> Schematic diagram of cell-oriented PDT(C-PDT) and vascular-targeted PDT (V-PDT). <bold>b</bold> The real-time changes of tumor vasculature undergo different treatment methods[<xref ref-type="bibr" rid="CR52">52</xref>] Copyright Â© 2019 Elsevier, Inc. <bold>c</bold> Ratios of CD8+:Treg (Pâ=â0.15) and Tconv:Treg cells (Pâ=â0.07) were calculated. <bold>d</bold> The lungs were taken on the 21st day and the CD8+/Treg and Tconv/Treg cell ratios were calculated. <bold>e</bold> VTP induced expression of PD-L1 in human RCC xenograft tumor [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p>(Copyright Â© 2017 American Association for Cancer Research)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig3_HTML.png" id="MO3"/></fig></p><p id="Par14">O'Shaughnessy et al. reported that vascular-targeted photodynamic (VTP) therapy-induced local immune response can enhance an immune response to PD-1 pathway inhibition. The PD-L1 expression can be induced by VTP in renal-cell carcinoma (RCC) xenograft [<xref ref-type="bibr" rid="CR53">53</xref>]. In the VTP+ antagonistic antibody (Abs) group, CD8<sup>+</sup> and Tconv cells played a role in combined treatment response. The ratio of CD8:Tregs to Tconv: Tregs returned to baseline 3Â days after treatment (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>c). The ratio of CD8<sup>+</sup>:Treg and Tconv: Treg cells was also dropped in the VTP+ Abs group compared to the control group or monotherapy treated animals (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>d). The tumor was treated with VTP, then the expression of PD-L1 was quantitatively evaluated. The proportion of cells expressing PD-L1 increased after VTP treatment compared with untreated tumors in both xenograft models. In Both A-498 and 786-O tumors, the expression of PD-L1 peaked 5Â h and 24Â h after VTP treatment (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>e).</p><p id="Par15">The VTP can destroy vascular endothelium and cause vascular obstruction. For larger tumors, the tumor blood vessels are larger. Even if the VTP can cause damage to tumor blood vessels, it is relatively mild and cannot block blood vessels. So the treatment of the primary tumor is not as effective as the treatment of the smaller tumor. This is the key problem to be solved in vascular-targeted photodynamic immunotherapy.</p></sec></sec><sec id="Sec5"><title>Nano-chemical photodynamic immunotherapy</title><p id="Par16">Administered chemotherapeutic drugs may cause chemosensitivity reduction, drug resistance, and organ toxicities. Nanomaterials can enhance drug stability and increase drug-associated cytotoxicities, while reducing systemic toxicity via releasing encapsulated drugs by triggered of light. Some chemotherapeutic drug like mitoxantrone (MX) is also photosensitizer. Therefore, MX can act as a photosensitizer to generate <sup>1</sup>O<sub>2</sub> for PDT and an anti-tumor drug at the same time [<xref ref-type="bibr" rid="CR48">48</xref>]. Nanosized albumin-bound paclitaxel under targeted PDT also increases in the concentration of paclitaxel within the tumor [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par17">Nano-chemical PDT can enhance immune effects against tumors. Specifically, Kim e al. reported that the release rate of gemcitabine (GEM) due to disruption by ROS produced from PDT was increased. The drug delivery nanoplatform under PDT enhances the number of various immune cells, which are effective anti-tumor immunotherapy for biliary carcinoma (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>a) [<xref ref-type="bibr" rid="CR54">54</xref>]. Due to the lack of T lymphocyte production, there was no significant T cell fluorescence observed in BALB/c nude mouse tumors (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>b). In BALB/c mice, DSPE-PEG-pheophorbide A liposome (DPPL) combined with laser irradiation of GEM-loaded DSPE-PEG-pheophorbide A liposome (GDPPL) stimulated a large number of CD4<sup>+</sup> and CD8<sup>+</sup> T cells to infiltrate HUCCT-1 tumor tissue due to exogenous stimulation of photomediated affiliates, while the PBS, DPPL and GDPPL treatment groups did not receive laser irradiation without any immune cells (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>c).<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p><bold>a</bold> Graphical abstract of Gemcitabine-loaded DSPE-PEG-PheoA liposome-mediated photoimmunotherapy. Immune cells were recruited in vivo to detect tumor sections by PBS-, free GEM-(40Â mg/kg), DPPL- or GDPPL (GEM dose; 3Â mg/kg and/or PHEOA; <bold>b</bold> BALB/c nude mice and <bold>c</bold> BALB/c mice were irradiated with or without a 670Â nm laser (nâ=â4)(Scale barâ=â100Â Î¼m)[<xref ref-type="bibr" rid="CR54">54</xref>] </p><p>(Copyright Â© 2018 Elsevier Ltd)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig4_HTML.png" id="MO4"/></fig></p><p id="Par18">Chemotherapy at this stage is still effective in many tumors. But like a double-edged sword, its inevitable side effects seriously affect the quality of patients' life. The main reason is that its systemic application may bring inevitable damage to normal tissues and cells. Nanomaterials can accurately deliver chemotherapeutic drugs to the tumor to avoid systemic toxicity and increase the concentration of chemotherapeutic drugs in the tumor. By further use of immune response of chemotherapeutic drugs of nano-PDT, nano-chemical Photodynamic Immunotherapy will give chemotherapy a new life.</p></sec><sec id="Sec6"><title>Nano-immunogenic photodynamic immunotherapy</title><p id="Par19">Immunogenic cell death is followed by damage-associated molecular patterns (DAMPs), which serve as immunogenic signals to induce anti-tumor immunity. The immunogenic effects of PDT can be enhanced via nanomaterials to achieve better antitumor immune responses against metastasis of tumors.</p><p id="Par20">Oxygen-boosted PDT, by applying Fento-like-HaberâWeiss catalyst and MnO<sub>2</sub> to nanoplatform, can elicit ICD to release DAMPs, which induces immune and effector cell activation. Thus systematic anti-tumor immune response against metastasis was strongly induced [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Plasma membrane (PM)-targeted PDT can produce ROS to rupture PM followed by induction of ICD and fast release of DAMPs. Then, DAMPs would enhance anti-tumor immune response compared to that induced by cytoplasm-localized PDT (CP-PDT) [<xref ref-type="bibr" rid="CR57">57</xref>]. (A) Chimeric peptide (PCPK, PpIX-C6-PEG8-KKKKKKSKTKC-OMe) targets cell PM through farnesyltransferase (PFTase) farnesylation. (B) PM-PDT-induced necrosis and ICD combined with aPD-1 therapy (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>a). The PCPK group with light trigger showed much more matured DCs than other groups (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>b). PCPK-SR and PCPK groups without light-triggered showed a lower amount of tumor infiltrating lymphocytes in tumors. After photo-irradiation, TIL proportion in the PCPK group was higher than that in the PCPG-SR group, which indicates that PM-PDT has a strong immune stimulation ability. In the light group, the TILs of PCPKâ+âaPD-1 increased the most, indicating that PCPK-mediated PM-PDT can induce a stronger anti-tumor immune response, showing a more effective anti-tumor effect compared with the combination of aPD-1 therapy (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>c).<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p><bold>a</bold> Schematic diagram of PM-PDT in combination with aPD-1 therapy. <bold>b</bold> FACS assay of DC maturation (CD80+CD86+) in different treatments; Matured DCs with different treatments detected by Quantitative analysis(nâ=â3). <bold>c</bold> Detection of CD8<sup>+</sup> and CD4<sup>+</sup> cells by FACS assay[<xref ref-type="bibr" rid="CR57">57</xref>] </p><p>(Copyright Â© 2019 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig5_HTML.png" id="MO5"/></fig></p><p id="Par21">Oxygen-boosted PDT and PM-targeted PDT, like vascular-targeted PDT, achieve better immune response against tumors via enhancing the tumor-killing ability of PDT. As a result, PDT can be used alone or in combination with immunotherapy while its therapeutic effect on the tumor is enhanced. In this process, nanomaterials and nanotechnology play an important role in bridging the gap.</p></sec><sec id="Sec7"><title>Combination with immunotherapy</title><p id="Par22">Although PDT may induce anti-cancer immunity, such effects usually are not sufficient to kill the remaining tumor and inhibit distant tumors [<xref ref-type="bibr" rid="CR58">58</xref>]. To stimulate a strong anti-tumor immune response, a combination of therapy and multiple stimuli to expand immunogenicity is often necessary [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Fortunately, the emergence of nanomaterials holds great potential to circumvent the disadvantages of the effect of PDT on metastatic tumors due to their unique properties.</p><sec id="Sec8"><title>Nano-immuno-adjuvant photodynamic immunotherapy</title><p id="Par23">To improve PDT-induced immune response, an effective strategy is to develop immune potentiator nanocapsules. Rose Bengal (RB), a staining substance and a sensitizer, is a suitable candidate for such application [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par24">The combination of PDT and immune stimulation is also an effective strategy to enhance PDT-induced immune response. Nanoliposome encapsulating photosensitizer Chlorin e6 and Galectin-3 (Gal-3) inhibitor enhanced the ability of Natural Killer (NK) cells to recognize tumor cells after PDT [<xref ref-type="bibr" rid="CR62">62</xref>]. 5-Aminolevulinic acid (5-ALA) is a novel photoactivator with high selectivity and can be turned into photosensitizer PpIX. Nanocomplexes can help 5-ALA bypass the skin barrier directly to the tumor to produce more ROS after PDT. T cells are highly enhanced to exploit host immunity to remove metastases from lymphoid organs, accompanied by a strong inflammatory response and destruction of the primary tumor [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par25">Tumor Antigen is another immune enhancer that can be used in photodynamic immunotherapy. Xu et al. reported that mesoporous silica nanoparcicles (MSNs) with well-defined mesopores can successfully carry cancer vaccines to tumor sites avoiding rapid in vivo clearance [<xref ref-type="bibr" rid="CR64">64</xref>]. PDT recruited dendritic cells and induced neoantigen-specific, tumor-infiltrating T lymphocytes. PDT combined with individual tumor inoculation has a strong synergistic effect and has a strong anti-tumor effect on both local and distant tumors. The authors used the heterogeneous oilâwater double reaction system to synthesize bMSN. Ce6 and CpG were put into the mesopores of bMSNs, and after modification of bMSNs with PDP-PEG5k-NHS on the surface, the neoantigen peptide was conjugated to bMSNs. Laser irradiation (660Â nm) was used to produce cytotoxic ROS, eliminate tumor cells, trigger local immune activation, and realize anti-tumor immunity (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>a). Compared with other groups, the bMSN vaccineâ+âlaser group induced more T cells and DCs (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>b). Compared with the untreated or laser-treated soluble vaccine group (Pâ&lt;â0.01), bMSN significantly delayed the growth of primary tumors. Importantly, PDT combined with the bMSN vaccine further slowed the growth of both primary and contralateral tumors (Pâ&lt;â0.05) (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>c).<fig id="Fig6"><label>Fig. 6</label><caption xml:lang="en"><p><bold>a</bold> Schematic diagram of neoantigen-based photodynamic immunotherapy. <bold>b</bold> Meanwhile, frequencies of T cells and DCs were analyzed <bold>c</bold> Tumor growth curves of each group[<xref ref-type="bibr" rid="CR64">64</xref>] </p><p>(Copyright Â© 2019 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig6_HTML.png" id="MO6"/></fig></p></sec><sec id="Sec9"><title>Combination with blockade therapy</title><p id="Par26">Cancer immunotherapy has become an up-and-coming approach against cancer recently. Checkpoint blockade therapy has aroused great interest in recent years as promising immunotherapy for cancer [<xref ref-type="bibr" rid="CR65">65</xref>]. However, Checkpoint blockade immunotherapy has been shown to benefit a minority of patients.</p><p id="Par27">Checkpoint blockade immunotherapy only elicits limited a systemic anti-tumor response. PDT has shown the ability to induce a systemic anti-tumor immune response. Immunity-enhanced nano-PDT in combination with immune checkpoint inhibition might be a good strategy to eradicate both primary and metastatic tumors.</p><sec id="Sec10"><title>Combined with IDO inhibitor</title><p id="Par28">Enzyme IDO is an immune checkpoint, which highly expressed in tumors to prevent the T cell cloning expression and promote T cell dysfunction and apoptosis.</p><p id="Par29">Tumor-associated antigens released by ICD induced by PDT can be presented to T cells when combining checkpoint blockade cancer immunotherapy [<xref ref-type="bibr" rid="CR66">66</xref>â<xref ref-type="bibr" rid="CR68">68</xref>]. First of all, PDT applying PPIX-NLG@LIPo could directly kill primary cancer cells. Meanwhile, PDT combined with indoleamine 2,3-dioxygenase (IDO) therapy could induce more CD8<sup>+</sup>T cells to proliferate and infiltrate in tumors(Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>a) [<xref ref-type="bibr" rid="CR66">66</xref>]. The RAL nanoplatform can accumulate in the tumor area through the EPR effect. After intratumoral IND@RAL laser irradiation, ROS are generated inside the tumor, causing apoptosis of tumor cells. Furthermore, the IDO inhibitor released by the IND@RAL nano-probes responded to the high-reduction environment, reversing the immunosuppressive TME (Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>b) [<xref ref-type="bibr" rid="CR67">67</xref>]. The chimeric peptide PpIX-1MT includes 3 parts. Palmitic acid plus PpIX are taken to fabricate the hydrophobic central part of self-assembled nanoparticles. The PEG segment was utilized to stabilize the molecular structure and form the hydrophilic shells. In this study, murine colon cancer cells were injected intravenously to establish a mice model of pulmonary timorous metastasis. It is supposed to accumulate in the primary tumor with a sturdy EPR effect through injection of PpIX-1MT nanoparticles, which could produce ROS under light irradiation to induce tumor cell apoptosis. Subsequently, the caspase-3 released by the tumor cells promotes the releasing of 1MT, causing CD8<sup>+</sup>T cell activation through inhibition of the IDO pathway. It has effective inhibition and eradication effect on both primary tumor and lung metastasis (Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>c) [<xref ref-type="bibr" rid="CR68">68</xref>].<fig id="Fig7"><label>Fig. 7</label><caption xml:lang="en"><p><bold>a</bold>Schematic diagram of PpIX-NLG@Lipo for PDT and IDO blockade combination therapy[<xref ref-type="bibr" rid="CR66">66</xref>] Copyright Â© 2019Â Ivyspring International Publisher. (b) Schematic diagram of combined PDT and immunotherapy using IND@RAL for combating cancer [<xref ref-type="bibr" rid="CR67">67</xref>] CopyrightÂ© 2019 American Chemical Society. <bold>c</bold> A. The structure of PpIX-1MT. B. PDT leads to apoptosis and releasing of 1MT [<xref ref-type="bibr" rid="CR68">68</xref>] </p><p>(Copyright Â© 2018 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig7_HTML.png" id="MO7"/></fig></p><p id="Par30">An IDO inhibitor encapsulated in the nanoscale metalâorganic framework (nMOF) increased T cell infiltration. Synergistic PDT and IDO checkpoint blockade therapy achieves primary and metastatic tumor inhibition [<xref ref-type="bibr" rid="CR69">69</xref>]. Other two studies using the same IDO inhibitor loader liposome to achieve enhanced anti-tumor capability [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Caspase responsive peptide can be utilized to combine the photosensitizer and IDO inhibitor. Cascade synergism can effectively inhibit the primary tumor and lung metastatic tumor [<xref ref-type="bibr" rid="CR60">60</xref>]. Granzyme-B, CD8, CD86, and caspase-3 antibodies were used to label granzyme-B, CD8<sup>+</sup>T cells, DC cells, and dead cells respectively, to indicate the degree of immune response induced by each group. In comparison with PBS (+) group, the PpIX-1MT (+) group showed more granzyme-B, caspase-3, DC cells, and CD8<sup>+</sup>T cells in both primary tumor and lung (Fig.Â <xref rid="Fig8" ref-type="fig">8</xref>a). The immune-facilitate indexes include TNF-Î±, interferon-gamma (IFN-Î³), interleukin-17(IL-17), CD-8, CD-86, granzyme-B were ascending from PBS (+) group to PpIX-1MT (+) group (Fig.Â <xref rid="Fig10" ref-type="fig">10</xref>b). While the IL-10, a marker of immune suppression, showed the opposite tendency (Fig.Â <xref rid="Fig8" ref-type="fig">8</xref>b). Compared with other groups, no luminescence was found in the PpIX-1MT (+) group. By comparison, lung tissues from the other groups showed strong luminescence. The PpIX-1MT (+) group had almost no pulmonary tumorous nodules, while the other groups had a lot of pulmonary tumorous nodules (red arrow indicates lung tumor nodules). In particular, white tumorous nodules appeared in PpIX (+) group and 1MT (â) group, suggesting that neither PDT alone nor 1MT alone could eradicate pulmonary metastasis. H&amp;E staining of lung tissues was further to be confirmed (Fig.Â <xref rid="Fig8" ref-type="fig">8</xref>c).<fig id="Fig8"><label>Fig. 8</label><caption xml:lang="en"><p><bold>a</bold> Immunofluorescence of PBS and PpIX-1MT group. <bold>b</bold> Western blot analysis. <bold>c</bold> Evaluation of inhibition efficacy of lung metastasis [<xref ref-type="bibr" rid="CR60">60</xref>] </p><p>(Copyright Â© 2018 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig8_HTML.png" id="MO8"/></fig></p></sec><sec id="Sec11"><title>Combined with CTLA-4 checkpoint blockade therapy</title><p id="Par31">Multi-round PDT based on hydrogel in combination with anti-CTLA 4 therapy can not only inhibit the growth of the distant tumor, but also effectively protect immune memory and prevent tumor recurrence in a relatively long time [<xref ref-type="bibr" rid="CR70">70</xref>]. The mechanism of hydrogel-based photodynamic immunotherapy (Fig.Â <xref rid="Fig9" ref-type="fig">9</xref>a). Immunoadjuvant nanoparticles can promote a strong anti-tumor immunity in the presence of tumor-associated antigens produced by tumor photodynamic destruction. Thereby, immune adjuvant PDT combined with anti-CTLA 4 therapy has a good effect on the tumor under near-infrared laser irradiation and inhibits metastatic tumor growth after PDT [<xref ref-type="bibr" rid="CR58">58</xref>]. The underlying mechanism of immune memory against tumor recurrence are as follows (Fig.Â <xref rid="Fig9" ref-type="fig">9</xref>b).<fig id="Fig9"><label>Fig. 9</label><caption xml:lang="en"><p><bold>a</bold> This protocol elucidates the mechanism by which hydrogel-based photodynamic immunotherapy achieves systemic immune response. (1) The in situ gel is triggered by light so that the injected components can be maintained for a long time. (2) Remission of tumor hypoxia by catalase can enhance PDT and immunotherapy. (3) Tumor fragments and nano-adjuvant nanoplatform can induce a strong immune response. (4) Anti-tumor immunity can be further enhanced by checkpoint blockade that controls immune balance. (5) Under these synergistic mechanisms, gelatin-based PDT immunotherapy can effectively eliminate local, distal, and recurrent tumors[<xref ref-type="bibr" rid="CR70">70</xref>] Copyright Â© 2019 John Wiley &amp; Sons, Inc. <bold>b</bold> The mechanism of combined application of NIR-PDT and anti-CTLA 4 therapy was summarized. UCNP-Ce6-r837 nanoparticles can effectively perform photodynamic destruction on tumors under near-infrared light. Generated by the presence of tumor-associated antigen these nanoparticles as adjuvants can inhibit both primary and distant tumors and produce remaining immune memory [<xref ref-type="bibr" rid="CR58">58</xref>] </p><p>(Copyright Â© 2017 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig9_HTML.png" id="MO10"/></fig></p></sec><sec id="Sec12"><title>Combined with PD-1 and PD-L1 blockade therapy</title><p id="Par32">Wang et al. reported that the acid-activatable small interfering RNA (siRNA) micelleplexes combining PDT and aPD-L1 significantly enhanced the inhibition of primary and metastatic tumors (Fig.Â <xref rid="Fig10" ref-type="fig">10</xref>a). PDT or PD-L1 knockdown (KD) alone can attribute to tumor growth inhibition of ~â73% and ~â65%, respectively. It is worth noting that PDT and PD-L1 KD combined therapy fully abolished tumors with no weight loss (Fig.Â <xref rid="Fig10" ref-type="fig">10</xref>b). PDT combined with PD-L1 KD significantly inhibited metastatic lung tumor (Fig.Â <xref rid="Fig10" ref-type="fig">10</xref>c) [<xref ref-type="bibr" rid="CR71">71</xref>].<fig id="Fig10"><label>Fig. 10</label><caption xml:lang="en"><p><bold>a</bold> Schematic illustration acid-activated multifunctional micelleplexes are used in cancer photodynamic immunotherapy with PD-L1 blockade enhancement. <bold>b</bold> Photos of mice taken at first or seventh day after PDT and PD-L1-KD. <bold>c</bold> Images of metastatic foci [<xref ref-type="bibr" rid="CR71">71</xref>] </p><p>(CopyrightÂ© 2016 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig10_HTML.png" id="MO9"/></fig></p><p id="Par33">Targeting PDT promotes dendritic cell maturation and cytokine production, thereby stimulating activation of CD8<sup>+</sup> cytotoxic T lymphocytes. Therefore, Yu et al. reported that combining with aPD-1 therapy significantly inhibited second subcutaneous tumor and metastasis [<xref ref-type="bibr" rid="CR72">72</xref>]. The scheme of DSAB-HK PDT combined with aPD-1 therapy (Fig.Â <xref rid="Fig11" ref-type="fig">11</xref>a). aPD-1 therapy after DSAB-HK PDT significantly inhibited the second tumor growth (Fig.Â <xref rid="Fig11" ref-type="fig">11</xref>b). aPD-1 therapy after DSAB-HK PDT significantly prolonged survival (Fig.Â <xref rid="Fig11" ref-type="fig">11</xref>c). Combined with aPD-1 therapy, the inhibitory activation of the immune response caused by PDT also inhibited distant tumors [<xref ref-type="bibr" rid="CR60">60</xref>].<fig id="Fig11"><label>Fig. 11</label><caption xml:lang="en"><p><bold>a</bold> diagram of DSAB-HK PDT combined with aPD-1 therapy. <bold>b</bold>, <bold>c</bold> The growth curves of the second tumors (<bold>b</bold>) and survival curves of the mouse (<bold>c</bold>) after treatments and removal of first tumor [<xref ref-type="bibr" rid="CR72">72</xref>] CopyrightÂ Â© Ivyspring International Publisher. <bold>d</bold> ZnP@pyro PDT combined with aPD-L1 therapy can eradicate both primary and distant tumors via anti-tumor immunity. <bold>e</bold> Typical images of the nodules in the lung neoplasm are shown [<xref ref-type="bibr" rid="CR73">73</xref>] </p><p>(CopyrightÂ© 2016 American Chemical Society)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig11_HTML.png" id="MO11"/></fig></p><p id="Par34">Nanoparticle-mediated PDT that generating T cells enhances the systemic efficacy of aPD-1 therapy in primary tumors and lung metastases [<xref ref-type="bibr" rid="CR73">73</xref>]. Combination therapy of checkpoint blockade therapy and routine immunogenic therapy like PDT can significantly increase the ratio of tumor response to checkpoint therapy (Fig.Â <xref rid="Fig11" ref-type="fig">11</xref>d). Compared with the PBS control group, ZNp@Pyro PDT or anti-PD-L1 therapy alone showed little effect in preventing lung metastasis, while combination therapy significantly reduced tumor nodules (Fig.Â <xref rid="Fig11" ref-type="fig">11</xref>e).</p><p id="Par35">Chemotherapeutic drugs can enhance PDT evoked anticancer immune responses. Combined with aPD-L1 therapy, chemotherapeutic drugs loaded nanoparticles can both inhibit primary and distant tumor growth [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Under 660Â nm irradiation, encapsulated Ce6 produced ROS, which could induce PDT for cancer treatment and rapidly degraded TK-PPE, promoted the release of intracellular DOX, induced efficient chemotherapy-PDT cascade, and inhibited tumor growth through monotherapy. The cascaded chemo-PDT could lead to DOX-based chemotherapy-PDT induced ICD. Cascaded chemo-PDT further combined with aPD-L1 therapy effectively inhibits the growth of primary and cause distant tumors to degenerate through significant distal effects, demonstrating the enhanced effectiveness of checkpoint blockade antibodies (Fig.Â <xref rid="Fig12" ref-type="fig">12</xref>a) [<xref ref-type="bibr" rid="CR75">75</xref>]. Combined with aPD-L1 therapy, NCP@pyrolipid chemo-PDT greatly promotes the generation and infiltration of tumor-specific effecter T cells in tumors, resulting in the elimination of the main tumor site and a systemic anti-tumor immune response rejecting remote tumor (Fig.Â <xref rid="Fig12" ref-type="fig">12</xref>b) [<xref ref-type="bibr" rid="CR74">74</xref>].<fig id="Fig12"><label>Fig. 12</label><caption xml:lang="en"><p><bold>a</bold> The mechanism of TKHNPC/D-mediated chemo-PDT combined with aPD-L1 therapy to induce anti-tumor immune response[<xref ref-type="bibr" rid="CR75">75</xref>] Copyright Â© 2019 Elsevier Ltd. <bold>b</bold> Chemo-PDT of NCP@pyrolipid can enhance the aPD-L1 therapy and cause systemic anti-tumor immunity [<xref ref-type="bibr" rid="CR74">74</xref>] </p><p>(Copyright Â© 2016 Springer Nature Limited)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2021_903_Fig12_HTML.png" id="MO12"/></fig></p></sec></sec></sec><sec id="Sec13"><title>Conclusions and future challenges</title><p id="Par36">Owing to the extremely short diffusion range of singlet oxygen, it would be more effective to deliver photosensitizers directly to specific organelle to overcome hypoxia-induced PDT resistance. Nanomaterials that can regenerate and reperfuse O<sub>2</sub> can be used to deal with tumor hypoxia too. PDT can cause local damage to the tumor by direct cytotoxic effects and vascular damage, as well as inflammatory response. But the anti-tumor effects of PDT are usually inefficient in the complete eradication and long-term control over disseminating tumors. Supported by nanomaterials augmented systemic anti-tumor immunity, nanotechnology-based PDT destroys both primary and metastatic tumor in many types of tumors.</p><p id="Par37">PDT is seldom employed in deep-seated tumors on account of its poor tissue penetration by light. High penetrating microwave or X-ray irradiation of PSs can solve this problem.Â MW can induce heat to increase blood supply to enhance the PDT effect. The X-ray can also overcome the limits of tissue attenuation. X-ray activates PSs to generate ROS, which is used for X-ray-induced PDT. However, X-ray may be attenuated by hypoxia, this means more modalities are needed to yield X-ray and PDT synergistic anti-tumor effects. PSs cannot be activated directly by X-ray, so nanomaterials can be used to bridge the gaps and overcome the hypoxia in the tumor. Since X-ray is harmful to normal tissue, making X-ray-induced PDT less selective. Efforts should be focused on fabricating the best nanomaterials with fewer X-rays. Gas therapy is a novel treatment utilizing gas, including CO, NO, and H<sub>2</sub>S. PDT is oxygen-consuming and tumor hypoxia reduces the therapy efficiency. Small molecule NO has a far diffusion radius and long half-life in the hypoxic tumor microenvironment. Part of the ROS generated by PDT can play an oxidative role in transforming NO donors into NO, which significantly enhances the effect of PDT. Gas therapy and PDT can become an organic combination to achieve collaborative treatment [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par38">There have been numerous advancements in immunotherapy. However, immunotherapy alone is not effective for the treatment of cancer. In the combinational treatment of PDT and immunotherapy, PDT can target primary tumors that can not be treated by immunotherapy. Nanotechnology can be helpful to develop multimodal immunotherapy strategies for cancer therapy. The relationship between the human immune system and disease is complex and individually unique, which makes the immunotherapy effect compromised and difficult to predict. Immunotherapy combined with PDT base on nanotechnology might provide a more specific and hopeful treatment to fight the tumor. However, PDT-induced immunotherapy is badly impaired by T cell activities through the PD-1/PD-L1 immune checkpoint pathway. Compared with surgery or chemotherapy, both photodynamic and immunotherapy are minimally invasive treatments with lower side effects. But the effect of photodynamic therapy on the tumor is not as good as that of surgery and chemotherapy, which makes the effect of photodynamic immunotherapy on solid tumors questionable.</p><p id="Par39">The tumor-targeting ability of PDT is significantly limited by the tumor hypoxic microenvironment. Nanomaterials-based photodynamic immunotherapy by conjugating nanomaterials with tumor-targeted molecules and antibodies could improve the targeting ability of PDT. Nano-PDT can induce an immunogenic TME, which makes tumors sensitive to checkpoint blockade therapy. Nano-PDIT can inhibit metastatic tumors and have a long-term immune memory. Checkpoint blockade immunotherapy is very efficient but beneficial to only a small number of patients because of an inadequate immune response. When combining with nano-PDT, checkpoint blockade therapy can kill primary and metastatic tumors at the same time by activating host immune systems.</p><p id="Par40">Malignant brain cancers usually recur despite standard treatment of surgery followed by radiation therapy or chemotherapy, making it one of the most difficult challenges in cancer treatment. And PDT is a treatment option for brain cancer. Patients with recurrent anaplastic astrocytoma or with recurrent glioblastoma multiforme both had an extended median survival time after PDT [<xref ref-type="bibr" rid="CR77">77</xref>]. Except for intraoperative PDT, X-ray-induced PDT is a more minimally invasive treatment for brain cancer. Although the brain is not a part of systemic immune reactions, there is still some immunosuppression in brain tumors for immune protection [<xref ref-type="bibr" rid="CR78">78</xref>]. Therefore, nano-Photodynamic immunotherapy may be applied to brain cancer treatment for nanomaterials that can be utilized to control antigen and adjuvant delivery. But brain toxicity of nanomaterials needs to be studied fully.</p><p id="Par41">PDT and photothermal therapy (PTT) induces oxidative stress and thermal stress in tumor cell respectively. ROS induced by PDT can strengthen the immune response. Different from PDT, PTT causes tumor cell death by heat to release tumor-associated antigens into the surrounding environment to produce an anti-tumor response [<xref ref-type="bibr" rid="CR79">79</xref>]. Nanomaterials can then be applied to enhance the anti-tumor immunity of PDT and PTT accordingly. Since PDT procedures require sufficient oxygen, PTT can increase oxygen in the tumor by improving blood flow, combined PTT-PDT immunotherapy might be a promising anti-tumor treatment option. Although nanomaterials can achieve PTT-PDT, they still suffer from unclear toxicity.</p><p id="Par42">Although numerous preclinical studies have shown that photodynamic immunotherapy based on nanotechnology enhances immunity against primary and metastatic tumors simultaneously. However, this effect of nanotechnology-based photodynamic immunotherapy has not been examined clinically. Photodynamic therapy has clinically shown a good effect in the treatment of tumors of the body surface and cavity organs. Due to the limited tissue penetrating ability of light, for large solid tumors such as hepatocellular carcinoma, photodynamic immunotherapy can be performed by using hollow needles to puncture and insert photodynamic fibers multiple times.</p><p id="Par43">The safety of nanomaterials is a major future challenge for nano-photodynamic immunotherapy. However, for the safety of nanomaterials, cell and animal experiments are mainly carried out at the present stage, with few human experimental data. However, there are many kinds of nanomaterials, so it is necessary to carry out a lot of human toxicity experiments before they can be used in clinical practice.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="author-contribution"><title>Authorsâ contributions</title><p>Not applicable.</p></sec><sec><title>Funding</title><p>Not applicable.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec sec-type="ethics-statement"><title>Declarations</title><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par44">Not applicable.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par45">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare that they have no conflict of interest.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Cancer statistics</article-title><source>CA Cancer J Clin</source><year>2016</year><volume>66</volume><fpage>7</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">26742998</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>TJ</given-names></name><name><surname>Gomer</surname><given-names>CJ</given-names></name><name><surname>Henderson</surname><given-names>BW</given-names></name><name><surname>Jori</surname><given-names>G</given-names></name><name><surname>Kessel</surname><given-names>D</given-names></name><name><surname>Korbelik</surname><given-names>M</given-names></name><name><surname>Moan</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Q</given-names></name></person-group><article-title xml:lang="en">Photodynamic therapy</article-title><source>J Natl Cancer Inst</source><year>1998</year><volume>90</volume><fpage>889</fpage><lpage>905</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXktFOqsLY%3D</pub-id><pub-id pub-id-type="pmid">9637138</pub-id><pub-id pub-id-type="pmcid">4592754</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felsher</surname><given-names>DW</given-names></name></person-group><article-title xml:lang="en">Cancer revoked: oncogenes as therapeutic targets</article-title><source>Nat Rev Cancer</source><year>2003</year><volume>3</volume><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXjtlalsrc%3D</pub-id><pub-id pub-id-type="pmid">12724735</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedre</surname><given-names>M</given-names></name><name><surname>Patterson</surname><given-names>MS</given-names></name><name><surname>Wilson</surname><given-names>BC</given-names></name></person-group><article-title xml:lang="en">Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo</article-title><source>Photochem Photobiol</source><year>2002</year><volume>75</volume><fpage>382</fpage><lpage>391</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38Xjt1altb8%3D</pub-id><pub-id pub-id-type="pmid">12003128</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolik</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Anasagasti</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Measurement of the penetration depths of red and near infrared light in human âex vivoâ tissues</article-title><source>J Photochem Photobiol B</source><year>2000</year><volume>57</volume><issue>2</issue><fpage>90</fpage><lpage>93</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXosFektbo%3D</pub-id><pub-id pub-id-type="pmid">11154088</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Niu</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>AJ</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium Loaded graphene oxide</article-title><source>Biomaterials</source><year>2015</year><volume>42</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXitVyjsLbE</pub-id><pub-id pub-id-type="pmid">25542797</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AZ</given-names></name><name><surname>Langer</surname><given-names>R</given-names></name><name><surname>Farokhzad</surname><given-names>OC</given-names></name></person-group><article-title xml:lang="en">Nanoparticle delivery of cancer drugs</article-title><source>Annu Rev Med</source><year>2012</year><volume>63</volume><fpage>185</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xisleksb4%3D</pub-id><pub-id pub-id-type="pmid">21888516</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo</article-title><source>Adv Drug Deliv Rev</source><year>2013</year><volume>65</volume><fpage>71</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xhs1CjsbnI</pub-id><pub-id pub-id-type="pmid">23088862</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stylianopoulos</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">EPR-effect: utilizing size-dependent nano-particle delivery to solid tumors</article-title><source>Ther Deliv</source><year>2013</year><volume>4</volume><fpage>421</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXlt1ahtro%3D</pub-id><pub-id pub-id-type="pmid">23557281</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>R</given-names></name><name><surname>Mota</surname><given-names>H</given-names></name><name><surname>Bagnato</surname><given-names>VS</given-names></name><name><surname>Sibata</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Bio-nanotechnology and photodynamic therapy-State of the art review</article-title><source>Photodiagn Photodyn Ther</source><year>2008</year><volume>5</volume><fpage>19</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD1M3mvVagtQ%3D%3D</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatfield</surname><given-names>SM</given-names></name><name><surname>Kjaergaard</surname><given-names>J</given-names></name><name><surname>Lukashev</surname><given-names>D</given-names></name><name><surname>Schreiber</surname><given-names>TH</given-names></name><name><surname>Belikoff</surname><given-names>B</given-names></name><name><surname>Abbott</surname><given-names>R</given-names></name><name><surname>Sethumadhavan</surname><given-names>S</given-names></name><name><surname>Philbrook</surname><given-names>P</given-names></name><name><surname>Ko</surname><given-names>K</given-names></name><name><surname>Cannici</surname><given-names>R</given-names></name><name><surname>Thayer</surname><given-names>M</given-names></name><name><surname>Rodig</surname><given-names>S</given-names></name><name><surname>Kutok</surname><given-names>JL</given-names></name><name><surname>Jackson</surname><given-names>EK</given-names></name><name><surname>Karger</surname><given-names>B</given-names></name><name><surname>Podack</surname><given-names>ER</given-names></name><name><surname>Ohta</surname><given-names>A</given-names></name><name><surname>Sitkovsky</surname><given-names>MV</given-names></name></person-group><article-title xml:lang="en">Immunological mechanisms of the anti-tumor effects of supplemental oxygenation</article-title><source>Sci Transl Med</source><year>2015</year><volume>7</volume><issue>277</issue><fpage>277ra30</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXktF2ju74%3D</pub-id><pub-id pub-id-type="pmid">25739764</pub-id><pub-id pub-id-type="pmcid">4641038</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect</article-title><source>ACS Nano</source><year>2018</year><volume>12</volume><fpage>8633</fpage><lpage>8645</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhtlWgtbfF</pub-id><pub-id pub-id-type="pmid">30005164</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Xue</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Advances in nanomaterials for photodynamic therapy applications: status and challenges</article-title><source>Biomaterials</source><year>2020</year><volume>237</volume><fpage>119827</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXisVait7o%3D</pub-id><pub-id pub-id-type="pmid">32036302</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>CY</given-names></name><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Liang</surname><given-names>ZM</given-names></name><name><surname>Liang</surname><given-names>WY</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Ponraj</surname><given-names>J</given-names></name><name><surname>Dhanabalan</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>DY</given-names></name></person-group><article-title xml:lang="en">2D Nonlayered selenium nanosheets: facile synthesis, photoluminescence, and ultrafast photonics</article-title><source>Adv Opt Mater</source><year>2017</year><volume>5</volume><fpage>1700884</fpage></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Two-dimensional non-layered selenium nanoflakes: facile fabrications and applications for self-powered photo-detector</article-title><source>Nanotechnology</source><year>2019</year><volume>30</volume><issue>11</issue><fpage>114002</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhtFyhu7rM</pub-id><pub-id pub-id-type="pmid">30609416</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Xing</surname><given-names>CY</given-names></name><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Zhao</surname><given-names>JL</given-names></name><name><surname>Xiang</surname><given-names>YJ</given-names></name><name><surname>Guo</surname><given-names>ZN</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Yang</surname><given-names>ZG</given-names></name><name><surname>Dong</surname><given-names>BQ</given-names></name><name><surname>Qu</surname><given-names>JL</given-names></name><name><surname>Fan</surname><given-names>DY</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Ultrathin 2D nonlayered tellurium nanosheets: facile liquid-phase exfoliation, characterization, and photoresponse with high performance and enhanced stability</article-title><source>Adv Funct Mater</source><year>2018</year><volume>28</volume><issue>16</issue><fpage>1705833.1</fpage><lpage>1705833.11</lpage></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>MX</given-names></name><name><surname>Guo</surname><given-names>ZN</given-names></name><name><surname>Miao</surname><given-names>LL</given-names></name><name><surname>Han</surname><given-names>ST</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name><name><surname>Peng</surname><given-names>ZC</given-names></name></person-group><article-title xml:lang="en">Recent advancement in black phosphorus-based photonics, electronics, sensors and energy devices</article-title><source>Mater Horiz</source><year>2017</year><volume>4</volume><fpage>997</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhsVGkur3N</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>CY</given-names></name><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Zhao</surname><given-names>JL</given-names></name><name><surname>Ma</surname><given-names>DT</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Liang</surname><given-names>WY</given-names></name><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Dong</surname><given-names>BQ</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Ultrasmall bismuth quantum dots: facile liquid-phase exfoliation, characterization, and application in high-performance UVâvis photodetector</article-title><source>ACS Photonics</source><year>2018</year><volume>5</volume><issue>2</issue><fpage>621</fpage><lpage>629</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhvVait7nI</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>YZ</given-names></name><name><surname>Wu</surname><given-names>LM</given-names></name><name><surname>Ma</surname><given-names>DT</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Huang</surname><given-names>ZN</given-names></name><name><surname>Dai</surname><given-names>XY</given-names></name><name><surname>Xiang</surname><given-names>YJ</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Black-phosphorus-analogue tin monosulfide: an emerging optoelectronic two-dimensional material for high-performance photodetection with improved stability under ambient/harsh conditions</article-title><source>J Mater Chem C</source><year>2018</year><volume>6</volume><fpage>9582</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhsVCns7jL</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Qiao</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>ZN</given-names></name><name><surname>Ren</surname><given-names>XH</given-names></name><name><surname>Huang</surname><given-names>ZY</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Dhanabalan</surname><given-names>SC</given-names></name><name><surname>Ponraj</surname><given-names>JS</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Zhao</surname><given-names>JL</given-names></name><name><surname>Zhong</surname><given-names>JX</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">High-performance photo-electrochemical photodetector based on liquid-exfoliated few-layered in Se nanosheets with enhanced stability</article-title><source>Adv Funct Mater</source><year>2018</year><volume>28</volume><fpage>1705237</fpage></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>ZM</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Jiang</surname><given-names>XT</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Revealing of the ultrafast third-order nonlinear optical response and enabled photonic application in two-dimensional tin sulfide</article-title><source>Photonics Res</source><year>2019</year><volume>7</volume><issue>5</issue><fpage>494</fpage><lpage>502</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXit1egtrbO</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Zhu</surname><given-names>ZF</given-names></name><name><surname>Xu</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>YX</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>ZM</given-names></name><name><surname>Song</surname><given-names>YF</given-names></name><name><surname>Zou</surname><given-names>YS</given-names></name><name><surname>Zeng</surname><given-names>HB</given-names></name><name><surname>Xu</surname><given-names>SX</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>DY</given-names></name></person-group><article-title xml:lang="en">Broadband nonlinear photoresponse of 2D TiS<sub>2</sub> for ultrashort pulse generation and all-optical thresholding devices</article-title><source>Adv Opt Mater</source><year>2018</year><volume>6</volume><fpage>1701166</fpage></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YP</given-names></name><name><surname>Lim</surname><given-names>CK</given-names></name><name><surname>Dai</surname><given-names>ZG</given-names></name><name><surname>Yu</surname><given-names>GN</given-names></name><name><surname>Haus</surname><given-names>JW</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Prasad</surname><given-names>PN</given-names></name></person-group><article-title xml:lang="en">Photonics and optoelectronics using nano-structured hybrid perovskite media and their optical cavities</article-title><source>Phys Rep</source><year>2019</year><volume>795</volume><fpage>1</fpage><lpage>51</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXivVOnu78%3D</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>YF</given-names></name><name><surname>Liang</surname><given-names>ZM</given-names></name><name><surname>Jiang</surname><given-names>XT</given-names></name><name><surname>Chen</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>JL</given-names></name><name><surname>Lu</surname><given-names>SB</given-names></name><name><surname>Ji</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Few-layer antimonene decorated microfiber: ultra-short pulse generation and all-optical thresholding with enhanced long term stability</article-title><source>2D Mater</source><year>2017</year><volume>4</volume><issue>4</issue><fpage>045010</fpage></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>LM</given-names></name><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>YZ</given-names></name><name><surname>Jiang</surname><given-names>XT</given-names></name><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>SB</given-names></name><name><surname>Guo</surname><given-names>ZN</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xiang</surname><given-names>YJ</given-names></name><name><surname>Xu</surname><given-names>SX</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Fan</surname><given-names>DY</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Few-layer tin sulfide: a promising black-phosphorus analogue 2D material with exceptionally large nonlinear optical response, high stability, and applications in all-optical switching and wavelength conversion</article-title><source>Adv Opt Mater</source><year>2018</year><volume>6</volume><fpage>1700985</fpage></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>SH</given-names></name><name><surname>Wu</surname><given-names>ZX</given-names></name><name><surname>Wang</surname><given-names>ZX</given-names></name><name><surname>Wang</surname><given-names>DH</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Ge</surname><given-names>YQ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Sub-200 fs soliton mode-locked fiber laser based on bismuthene saturable absorber</article-title><source>Opt Expr</source><year>2018</year><volume>26</volume><issue>18</issue><fpage>22750</fpage><lpage>22760</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXisVersL7E</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>PF</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>TH</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Mu</surname><given-names>HR</given-names></name><name><surname>Shivananju</surname><given-names>BN</given-names></name><name><surname>Zhang</surname><given-names>YP</given-names></name><name><surname>Zhang</surname><given-names>QL</given-names></name><name><surname>Pan</surname><given-names>AL</given-names></name><name><surname>Li</surname><given-names>SJ</given-names></name><name><surname>Tang</surname><given-names>DY</given-names></name><name><surname>Jia</surname><given-names>BH</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Bao</surname><given-names>QL</given-names></name></person-group><article-title xml:lang="en">Two-dimensional CH3NH3PbI3 perovskite nanosheets for ultrafast pulsed fiber lasers</article-title><source>ACS Appl Mater Interfaces</source><year>2017</year><volume>9</volume><issue>14</issue><fpage>12759</fpage><lpage>12765</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXksVyktL4%3D</pub-id><pub-id pub-id-type="pmid">28317370</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Peng</surname><given-names>YP</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Xing</surname><given-names>CY</given-names></name><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>JQ</given-names></name></person-group><article-title xml:lang="en">Solar-inspired water purification based on emerging two-dimensional materials: status and challenges</article-title><source>Solar RRL</source><year>2020</year><pub-id pub-id-type="doi">10.1002/solr.201900400</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>ZJ</given-names></name><name><surname>Duo</surname><given-names>YH</given-names></name><name><surname>Lin</surname><given-names>ZT</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Xing</surname><given-names>CY</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>RH</given-names></name><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YP</given-names></name><name><surname>Zhao</surname><given-names>YH</given-names></name><name><surname>Yan</surname><given-names>XB</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">The Rise of 2D Photothermal materials beyond graphene for clean water production</article-title><source>Adv Sci</source><year>2020</year><volume>7</volume><issue>5</issue><fpage>1902236</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXnsVSisrY%3D</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>DT</given-names></name><name><surname>Li</surname><given-names>YL</given-names></name><name><surname>Mi</surname><given-names>HW</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>PX</given-names></name><name><surname>Lin</surname><given-names>ZQ</given-names></name><name><surname>Li</surname><given-names>JQ</given-names></name></person-group><article-title xml:lang="en">Robust SnO<sub>2</sub>-x nanoparticle-impregnated carbon nanofibers with outstanding electrochemical performance for advanced sodium-ion batteries</article-title><source>Angew Chem</source><year>2018</year><volume>57</volume><issue>29</issue><fpage>8901</fpage><lpage>8905</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXptFSgtb4%3D</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>MM</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">2D Black phosphorusâbased biomedical applications</article-title><source>Adv Funct Mater</source><year>2019</year><volume>29</volume><issue>13</issue><fpage>1808306</fpage></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname><given-names>AR</given-names></name><name><surname>Pons</surname><given-names>T</given-names></name><name><surname>Medintz</surname><given-names>IL</given-names></name><name><surname>Delehanty</surname><given-names>JB</given-names></name><name><surname>Melinger</surname><given-names>JS</given-names></name><name><surname>Tiefenbrunn</surname><given-names>T</given-names></name><name><surname>Dawson</surname><given-names>PE</given-names></name><name><surname>Fisher</surname><given-names>BR</given-names></name><name><surname>O'Rourke</surname><given-names>B</given-names></name><name><surname>Mattoussi</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Two-photon excitation of quantum-dot-based fluorescence resonance energy transfer and its applications</article-title><source>Adv Mater</source><year>2007</year><volume>19</volume><fpage>1921</fpage><lpage>1926</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXpsVGru7o%3D</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group><article-title xml:lang="en">Ag2S quantum dot: a bright and biocompatible fluorescent nanoprobe in the second near-infrared window</article-title><source>ACS Nano</source><year>2012</year><volume>6</volume><fpage>3695</fpage><lpage>3702</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XlvVSjs7Y%3D</pub-id><pub-id pub-id-type="pmid">22515909</pub-id><pub-id pub-id-type="pmcid">22515909</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Nanobiomaterials: from 0D to 3D for tumor therapy and tissue regeneration</article-title><source>Nanoscale</source><year>2019</year><volume>11</volume><fpage>13678</fpage><lpage>13708</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXht1entLfK</pub-id><pub-id pub-id-type="pmid">31292580</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Biochemistry and biomedicine of quantum dots: from biodetection to bioimaging, drug discovery, diagnostics, and therapy</article-title><source>Acta Biomater</source><year>2018</year><volume>74</volume><fpage>36</fpage><lpage>55</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXps1Ojsrs%3D</pub-id><pub-id pub-id-type="pmid">29734008</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Carbon-based materials for photodynamic therapy: a mini-review</article-title><source>Front Chem Sci Eng</source><year>2019</year><volume>13</volume><fpage>310</fpage><lpage>323</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXisFSgu7vE</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>XB</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">A smart photosensitizer-manganese dioxide nanosystem for enhanced photo-dynamic therapy by reducing glutathione levels in cancer cells</article-title><source>Angew Chem Int Ed</source><year>2016</year><volume>55</volume><fpage>5477</fpage><lpage>5482</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XkvVChs7g%3D</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Break-up of two-dimensional MnO<sub>2</sub> nanosheets promotes ultrasensitive pH-triggered theranostics of cancer</article-title><source>Adv Mater</source><year>2014</year><volume>26</volume><fpage>7019</fpage><lpage>7026</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhsVSmsrvI</pub-id><pub-id pub-id-type="pmid">25156250</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Structure-property relationships in manganese oxide-mesoporous silica nanoparticles used for T 1-weighted MRI and simultaneous anti- cancer drug delivery</article-title><source>Biomaterials</source><year>2012</year><volume>33</volume><fpage>2388</fpage><lpage>2398</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xnt1emtg%3D%3D</pub-id><pub-id pub-id-type="pmid">22177841</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Shang</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">2D transition metal dichalcogenide na-nosheets for photo/thermo-based tumor imaging and therapy</article-title><source>Nanoscale Horizons</source><year>2018</year><volume>3</volume><fpage>74</fpage><lpage>89</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhslChtrvF</pub-id><pub-id pub-id-type="pmid">32254070</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>LS</given-names></name><name><surname>Cong</surname><given-names>ZX</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ke</surname><given-names>KM</given-names></name><name><surname>Guo</surname><given-names>SS</given-names></name><name><surname>Yang</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>GN</given-names></name></person-group><article-title xml:lang="en">Graphitic-phase C<sub>3</sub>N<sub>4</sub> nanosheets as efficient photosensitizers and pH-responsive drug nanocarriers for cancer imaging and therapy</article-title><source>J Mater Chem B</source><year>2014</year><volume>2</volume><fpage>1031</fpage><lpage>1037</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhsF2qsrY%3D</pub-id><pub-id pub-id-type="pmid">32261621</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Sang</surname><given-names>DK</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">THz photonics in two dimensional materials and metamaterials: properties, devices and prospects</article-title><source>J Mater Chem C</source><year>2018</year><volume>6</volume><fpage>1291</fpage><lpage>1306</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXitlyksw%3D%3D</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sang</surname><given-names>DK</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>B</given-names></name><name><surname>Xing</surname><given-names>F</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Bao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXitlersA%3D%3D</pub-id><pub-id pub-id-type="pmid">29295927</pub-id><pub-id pub-id-type="pmcid">5776980</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Two-dimensional black phosphorus nanosheets for theranostic nanomedicine</article-title><source>Mater Horizons</source><year>2017</year><volume>4</volume><fpage>800</fpage><lpage>816</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtVGksbrM</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CM</given-names></name><name><surname>Lu</surname><given-names>TY</given-names></name></person-group><article-title xml:lang="en">C60 fullerene derivatized nanoparticles and their application to therapeutics</article-title><source>Recent Pat Nanotechnol</source><year>2012</year><volume>6</volume><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XnsVKlt7w%3D</pub-id><pub-id pub-id-type="pmid">22455733</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>CW</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Pu</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Recent progresses in phototherapy-synergized cancer immunotherapy</article-title><source>Adv Funct Mater</source><year>2018</year><volume>28</volume><fpage>1804688</fpage></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledford</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Immunotherapyâs cancer remit widens</article-title><source>Nature</source><year>2013</year><volume>497</volume><fpage>544</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXosVCitro%3D</pub-id><pub-id pub-id-type="pmid">23719439</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>YL</given-names></name><name><surname>Jia</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>YN</given-names></name><name><surname>Tang</surname><given-names>QS</given-names></name></person-group><article-title xml:lang="en">Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma</article-title><source>Nanoscale</source><year>2018</year><volume>10</volume><issue>14</issue><fpage>6511</fpage><lpage>6523</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXjsVGhurg%3D</pub-id><pub-id pub-id-type="pmid">29569668</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanaoka</surname><given-names>H</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>R</given-names></name><name><surname>Phung</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Choyke</surname><given-names>PL</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Photoimmunotherapy of hepatocellular carcinoma-targeting glypican-3 combined with nanosized albumin-bound paclitaxel</article-title><source>Nanomedicine (Lond)</source><year>2015</year><volume>10</volume><issue>7</issue><fpage>1139</fpage><lpage>1147</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXnsFemtLw%3D</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>XH</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>LQ</given-names></name><name><surname>Lai</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>CR</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>LJ</given-names></name><name><surname>Jia</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>XY</given-names></name><name><surname>Liu</surname><given-names>ZF</given-names></name></person-group><article-title xml:lang="en">Inhibiting metastasis and preventing tumor relapse by triggering host immunity with tumor-targeted photodynamic therapy using photosensitizer-loaded functional nanographenes</article-title><source>ACS Nano</source><year>2017</year><volume>11</volume><issue>10</issue><fpage>10147</fpage><lpage>10158</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhsVyqu7%2FP</pub-id><pub-id pub-id-type="pmid">28901740</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhen</surname><given-names>ZP</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>MZ</given-names></name><name><surname>Zhou</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>ZH</given-names></name><name><surname>Hao</surname><given-names>ZL</given-names></name><name><surname>Li</surname><given-names>ZB</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Protein nanocage mediated fibroblast-activation protein targeted photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control</article-title><source>Nano Lett</source><year>2017</year><volume>17</volume><issue>2</issue><fpage>862</fpage><lpage>869</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XitFGgtL%2FO</pub-id><pub-id pub-id-type="pmid">28027646</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>MR</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>DQ</given-names></name><name><surname>Ge</surname><given-names>JC</given-names></name><name><surname>Deng</surname><given-names>RJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>JJ</given-names></name><name><surname>Zou</surname><given-names>TJ</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><name><surname>Shu</surname><given-names>CY</given-names></name></person-group><article-title xml:lang="en">Photo-triggered gadofullerene: enhanced cancer therapy by combining tumor vascular disruption and stimulation of anti-tumor immune responses</article-title><source>Biomaterials</source><year>2019</year><volume>213</volume><fpage>119218</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhtVeitrrE</pub-id><pub-id pub-id-type="pmid">31136911</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>OâShanughnessy</surname><given-names>MJ</given-names></name><name><surname>Murray</surname><given-names>KS</given-names></name><name><surname>La Rosa</surname><given-names>SP</given-names></name><name><surname>Budhu</surname><given-names>S</given-names></name><name><surname>Merghoub</surname><given-names>T</given-names></name><name><surname>Somma</surname><given-names>A</given-names></name><name><surname>Monette</surname><given-names>S</given-names></name><name><surname>Kin</surname><given-names>KH</given-names></name><name><surname>Corradi</surname><given-names>RB</given-names></name><name><surname>Scherz</surname><given-names>A</given-names></name><name><surname>Coleman</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Systemic anti-tumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors</article-title><source>Clin Cancer Res</source><year>2018</year><volume>24</volume><issue>3</issue><fpage>592</fpage><lpage>599</lpage></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Im</surname><given-names>BN</given-names></name><name><surname>Hwang</surname><given-names>HS</given-names></name><name><surname>Na</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Gemcitabine-loaded DSPE-PEG-PheoA liposome as a photomediated immune modulator for cholangiocarcinoma treatment</article-title><source>Biomaterials</source><year>2018</year><volume>11</volume><issue>183</issue><fpage>139</fpage><lpage>150</lpage></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>YB</given-names></name><name><surname>Liu</surname><given-names>HH</given-names></name><name><surname>Ren</surname><given-names>F</given-names></name><name><surname>Zeng</surname><given-names>JF</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>MY</given-names></name></person-group><article-title xml:lang="en">Light-enhanced O<sub>2</sub>-evolving nanoparticles boost photodynamic therapy to elicit anti-tumor immunity</article-title><source>ACS Appl Mater Interfaces</source><year>2019</year><volume>11</volume><issue>18</issue><fpage>16367</fpage><lpage>16379</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXns1Cgu78%3D</pub-id><pub-id pub-id-type="pmid">30994323</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>LL</given-names></name><name><surname>He</surname><given-names>HM</given-names></name><name><surname>Chen</surname><given-names>ZK</given-names></name><name><surname>Han</surname><given-names>ZQ</given-names></name><name><surname>Luo</surname><given-names>ZY</given-names></name><name><surname>Wu</surname><given-names>ZH</given-names></name><name><surname>Zheng</surname><given-names>MB</given-names></name><name><surname>Ma</surname><given-names>TT</given-names></name><name><surname>Cai</surname><given-names>LT</given-names></name></person-group><article-title xml:lang="en">Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases</article-title><source>Biomaterials</source><year>2018</year><volume>177</volume><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhtFSnsr%2FE</pub-id><pub-id pub-id-type="pmid">29890364</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Qiu</surname><given-names>WX</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>RQ</given-names></name><name><surname>Zhuang</surname><given-names>ZN</given-names></name><name><surname>Yu</surname><given-names>WY</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>XZ</given-names></name></person-group><article-title xml:lang="en">Enzyme-driven membrane-targeted chimeric peptide for enhanced tumor photodynamic immunotherapy</article-title><source>ACS Nano</source><year>2019</year><volume>13</volume><issue>10</issue><fpage>11249</fpage><lpage>11262</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhvVKltbnF</pub-id><pub-id pub-id-type="pmid">31566945</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Zhuang</surname><given-names>Q</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer</article-title><source>ACS Nano</source><year>2017</year><volume>11</volume><fpage>4463</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXlsVentrw%3D</pub-id><pub-id pub-id-type="pmid">28362496</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngwa</surname><given-names>W</given-names></name><name><surname>Irabor</surname><given-names>OC</given-names></name><name><surname>Schoenfeld</surname><given-names>JD</given-names></name><name><surname>Hesser</surname><given-names>J</given-names></name><name><surname>Demaria</surname><given-names>S</given-names></name><name><surname>Formenti</surname><given-names>SC</given-names></name></person-group><article-title xml:lang="en">Using immunotherapy to boost the abscopal effect</article-title><source>Nat Rev Cancer</source><year>2018</year><volume>18</volume><fpage>313</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXivVSiu7s%3D</pub-id><pub-id pub-id-type="pmid">29449659</pub-id><pub-id pub-id-type="pmcid">5912991</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>WL</given-names></name><name><surname>Pike</surname><given-names>LRG</given-names></name><name><surname>Royce</surname><given-names>TJ</given-names></name><name><surname>Mahal</surname><given-names>BA</given-names></name><name><surname>Loeffler</surname><given-names>JS</given-names></name></person-group><article-title xml:lang="en">Safety of combining radiotherapy with immune-checkpoint inhibition</article-title><source>Nat Rev Clin Oncol</source><year>2018</year><volume>15</volume><fpage>477</fpage><pub-id pub-id-type="pmid">29872177</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>JP</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>DD</given-names></name></person-group><article-title xml:lang="en">Multifunctional nanocapsules on a seesaw balancing sonodynamic and photodynamic therapies against superficial malignant tumors by effective immune-enhancement</article-title><source>Biomaterials</source><year>2019</year><volume>218</volume><fpage>119251</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXht1CmsL3L</pub-id><pub-id pub-id-type="pmid">31319284</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Liu</surname><given-names>HF</given-names></name><name><surname>Xin</surname><given-names>J</given-names></name><name><surname>Rahmanzadeh</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>CP</given-names></name><name><surname>Zhang</surname><given-names>ZX</given-names></name></person-group><article-title xml:lang="en">Chlorin-based photoactivable Galectin-3-inhibitor nanoliposome for enhanced photodynamic therapy and NK cell-related immunity in Melanoma</article-title><source>ACS Appl Mater Interfaces</source><year>2019</year><volume>11</volume><issue>45</issue><fpage>41829</fpage><lpage>41841</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhvFKkt77F</pub-id><pub-id pub-id-type="pmid">31617343</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>CF</given-names></name><name><surname>Deng</surname><given-names>HH</given-names></name><name><surname>Wu</surname><given-names>JM</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>HB</given-names></name><name><surname>Xiong</surname><given-names>XX</given-names></name><name><surname>Feng</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Robust photodynamic therapy using 5-ALA-incorporated nanocomplexes cures metastatic melanoma through priming of CD4<sup><bold>+</bold></sup>CD8<sup><bold>+</bold></sup> double positive T cells</article-title><source>Adv Sci (Weinh)</source><year>2019</year><volume>6</volume><issue>5</issue><fpage>1802057</fpage></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Nam</surname><given-names>JT</given-names></name><name><surname>Hong</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Moon</surname><given-names>JJ</given-names></name></person-group><article-title xml:lang="en">Positron emission tomography-guided photodynamic therapy with biodegradable mesoporous silica nanoparticles for personalized cancer immunotherapy</article-title><source>ACS Nano</source><year>2019</year><volume>13</volume><issue>10</issue><fpage>12148</fpage><lpage>12161</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhvVCntLvI</pub-id><pub-id pub-id-type="pmid">31556987</pub-id><pub-id pub-id-type="pmcid">6832743</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>DG</given-names></name><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name><name><surname>Yu</surname><given-names>HJ</given-names></name><name><surname>Jiao</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>FY</given-names></name><name><surname>Fu</surname><given-names>YL</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>PC</given-names></name></person-group><article-title xml:lang="en">Acid-activatable versatile micelleplexes for PD-L1 blockade-enhanced cancer photodynamic immunotherapy</article-title><source>Nano Lett</source><year>2016</year><volume>16</volume><issue>9</issue><fpage>5503</fpage><lpage>5513</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtlehsrfP</pub-id><pub-id pub-id-type="pmid">27525587</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ZQ</given-names></name><name><surname>Wei</surname><given-names>GF</given-names></name><name><surname>Zeng</surname><given-names>ZS</given-names></name><name><surname>Huang</surname><given-names>YJ</given-names></name><name><surname>Huang</surname><given-names>LF</given-names></name><name><surname>Shen</surname><given-names>YF</given-names></name><name><surname>Sun</surname><given-names>XQ</given-names></name><name><surname>Xu</surname><given-names>CJ</given-names></name><name><surname>Zhao</surname><given-names>CS</given-names></name></person-group><article-title xml:lang="en">Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor</article-title><source>Tharanostics</source><year>2019</year><volume>9</volume><issue>19</issue><fpage>5542</fpage><lpage>5557</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXkvVSgtb4%3D</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DC</given-names></name><name><surname>Chen</surname><given-names>BL</given-names></name><name><surname>Mo</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>Qi</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>YG</given-names></name></person-group><article-title xml:lang="en">Redox-activated porphyrin-based liposome remote-loadedwith IDO inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of IDO pathway</article-title><source>Nano Lett</source><year>2019</year><volume>19</volume><issue>10</issue><fpage>6964</fpage><lpage>6976</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhslyjsr3L</pub-id><pub-id pub-id-type="pmid">31518149</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Kuang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>CX</given-names></name><name><surname>Zhang</surname><given-names>MK</given-names></name><name><surname>Zheng</surname><given-names>DW</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>XZ</given-names></name></person-group><article-title xml:lang="en">Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication</article-title><source>ACS Nano</source><year>2018</year><volume>12</volume><issue>2</issue><fpage>1978</fpage><lpage>1989</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXisFamu70%3D</pub-id><pub-id pub-id-type="pmid">29420012</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellman</surname><given-names>I</given-names></name><name><surname>Coukos</surname><given-names>G</given-names></name><name><surname>Dranoff</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Cancer immunotherapy comes of age</article-title><source>Nature</source><year>2011</year><volume>480</volume><fpage>480</fpage><lpage>489</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhs1GksLjO</pub-id><pub-id pub-id-type="pmid">22193102</pub-id><pub-id pub-id-type="pmcid">3967235</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>ZQ</given-names></name><name><surname>Zhou</surname><given-names>XF</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>ZL</given-names></name><name><surname>Wang</surname><given-names>HR</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>She</surname><given-names>JL</given-names></name><name><surname>Xu</surname><given-names>LG</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations</article-title><source>Adv Mater</source><year>2019</year><volume>31</volume><issue>24</issue><fpage>e1900927</fpage><pub-id pub-id-type="pmid">31012164</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>KD</given-names></name><name><surname>He</surname><given-names>CB</given-names></name><name><surname>Guo</surname><given-names>NN</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Ni</surname><given-names>KY</given-names></name><name><surname>Weichselbaum</surname><given-names>RR</given-names></name><name><surname>Lin</surname><given-names>WB</given-names></name></person-group><article-title xml:lang="en">Chlorin-based nanoscale metalâorganic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy</article-title><source>J Am Chem Soc</source><year>2016</year><volume>138</volume><issue>38</issue><fpage>12502</fpage><lpage>12510</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsVChtr%2FM</pub-id><pub-id pub-id-type="pmid">27575718</pub-id><pub-id pub-id-type="pmcid">5673483</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>LQ</given-names></name><name><surname>Zhang</surname><given-names>CR</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>XH</given-names></name><name><surname>Lai</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>ZF</given-names></name></person-group><article-title xml:lang="en">Enhanced anti-tumor efficacy through a combination of integrin Î±vÎ²6-targeted photodynamic therapy and immune checkpoint inhibition</article-title><source>Theranostics</source><year>2016</year><volume>6</volume><issue>5</issue><fpage>627</fpage><lpage>637</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtFWmtrbI</pub-id><pub-id pub-id-type="pmid">27022411</pub-id><pub-id pub-id-type="pmcid">4805658</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>XP</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>NN</given-names></name><name><surname>Han</surname><given-names>WB</given-names></name><name><surname>Weichselbaum</surname><given-names>RR</given-names></name><name><surname>Lin</surname><given-names>WB</given-names></name></person-group><article-title xml:lang="en">Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergize with immune checkpoint blockade to elicit anti-tumor immunity and antimetastatic effect on breast cancer</article-title><source>J Am Chem Soc</source><year>2016</year><volume>138</volume><issue>51</issue><fpage>16686</fpage><lpage>16695</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhvFyntbzM</pub-id><pub-id pub-id-type="pmid">27976881</pub-id><pub-id pub-id-type="pmcid">5667903</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>CB</given-names></name><name><surname>Duan</surname><given-names>XP</given-names></name><name><surname>Guo</surname><given-names>NN</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Poon</surname><given-names>C</given-names></name><name><surname>Weichselbaum</surname><given-names>RR</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>12499</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xhtlyltr7N</pub-id><pub-id pub-id-type="pmid">27530650</pub-id><pub-id pub-id-type="pmcid">4992065</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">The potentiated checkpoint blockade immunotherapy by ROS responsive nanocarrier-mediated cascade chemo-photodynamic therapy</article-title><source>Biomaterials</source><year>2019</year><volume>223</volume><fpage>119469</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhslGmt7fP</pub-id><pub-id pub-id-type="pmid">31520886</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>SS</given-names></name><name><surname>Zeng</surname><given-names>JY</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>XZ</given-names></name></person-group><article-title xml:lang="en">ROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor</article-title><source>Biomaterials</source><year>2018</year><volume>12</volume><issue>185</issue><fpage>51</fpage><lpage>62</lpage></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stylli</surname><given-names>SS</given-names></name><name><surname>Kaye</surname><given-names>AH</given-names></name><name><surname>Macgregor</surname><given-names>L</given-names></name><name><surname>Howes</surname><given-names>M</given-names></name><name><surname>Rajendra</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Photodynamic therapy of high grade glioma: long term survival</article-title><source>J Clin Neurosci</source><year>2005</year><volume>12</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXltVOntLo%3D</pub-id><pub-id pub-id-type="pmid">15925768</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orive</surname><given-names>G</given-names></name><name><surname>Ali</surname><given-names>OA</given-names></name><name><surname>Anitua</surname><given-names>E</given-names></name><name><surname>Pedraz</surname><given-names>JL</given-names></name><name><surname>Emerich</surname><given-names>DF</given-names></name></person-group><article-title xml:lang="en">Biomaterial-based technologies for brain anti-cancer therapeutics and imaging</article-title><source>Biochim Biophys Acta</source><year>2010</year><volume>1806</volume><issue>1</issue><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXntlGju7s%3D</pub-id><pub-id pub-id-type="pmid">20406668</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>RH</given-names></name><name><surname>Zou</surname><given-names>MZ</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>SY</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>XF</given-names></name><name><surname>Chen</surname><given-names>HS</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>PH</given-names></name><name><surname>Zhang</surname><given-names>XZ</given-names></name></person-group><article-title xml:lang="en">Nanoparticles from cuttlefish ink inhibit tumor growth by synergizing immunotherapy and photothermal therapy</article-title><source>ACS Nano</source><year>2019</year><volume>13</volume><fpage>8618</fpage><lpage>8629</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXht1Oqsb3L</pub-id><pub-id pub-id-type="pmid">31246413</pub-id></mixed-citation></ref></ref-list></ref-list><notes notes-type="Misc"><title>Publisher's Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biotechnology</facet-value><facet-value count="1">Chemistry</facet-value><facet-value count="1">Molecular Medicine</facet-value><facet-value count="1">Nanotechnology</facet-value></facet><facet name="keyword"><facet-value count="1">Cancer treatment</facet-value><facet-value count="1">Immunotherapy</facet-value><facet-value count="1">Nanotechnology</facet-value><facet-value count="1">Photodynamic therapy</facet-value></facet><facet name="pub"><facet-value count="1">Journal of Nanobiotechnology</facet-value></facet><facet name="year"><facet-value count="1">2021</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
